S
Senomyx
Using proprietary taste receptor technologies to discover and develop novel flavor ingredients
About Senomyx
Senomyx, Inc. operates as a biotechnology company focused on the food and beverage industry, leveraging proprietary technology to discover and develop novel flavor ingredients and taste modulators. Founded in 1998 as Ambryx, Inc. by biochemist Lubert Stryer and Paul Nevsky, the company rebranded as Senomyx in 2000. Stryer, a distinguished professor at Stanford University School of Medicine, brought a wealth of knowledge from his extensive research on the interplay of light and life, which had significant applications in genetic analysis and understanding sensory processes. His academic and entrepreneurial background, including co-founding Affymax, was instrumental in shaping Senomyx's scientific direction.
The company's core business revolves around its taste receptor-based assay systems. These platforms utilize isolated human taste receptors to screen for compounds that can modify or enhance flavors. Senomyx's technology aims to identify ingredients that can reduce the need for sugar, salt, and monosodium glutamate (MSG) in consumer products, addressing a growing demand for healthier food options without compromising taste. Its programs have focused on savory, sweet, salt, bitter, and cooling taste areas. The business model is centered on collaborative research and development agreements with major global food, beverage, and ingredient supply companies. Partners, which have included Nestlé, Coca-Cola, PepsiCo, Campbell Soup Company, and Firmenich, receive exclusive or co-exclusive rights to use the discovered flavor ingredients in specific product categories and geographies. In return, Senomyx earned research and development funding, milestone payments, and royalties on the sales of products incorporating its ingredients.
Senomyx's product offerings are not sold directly to consumers but are integrated into the products of its corporate partners. These ingredients function as flavor enhancers, such as those that amplify the taste of sucrose (sugar) or sucralose, or as bitter blockers. Because they are used in minute quantities, often less than one part per million, they are typically classified under the general heading of "artificial flavors" on ingredient lists. A key milestone was achieved when its savory enhancer received a "generally recognized as safe" (GRAS) status from the Flavor and Extract Manufacturers Association. After years of operation and numerous partnerships, Senomyx was acquired by the Swiss flavor and fragrance company Firmenich in September 2018 for approximately $72 million, subsequently becoming a wholly-owned subsidiary and ceasing to trade on the NASDAQ.
Source: Dealroom company dataAt a glance
- Founded
- 1998
- Headquarters
- San Diego, United States
- Sector
- Biotech & Life Sciences
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
- BCBay City Capital
Rho Ventures
Domain Associates
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Senomyx on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Senomyx on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.